Guizhou Bailing Group Pharmaceutical Co.,Ltd.’s Net Profit Rose 24.1% in 2022

Guizhou Bailing Group Pharmaceutical Co.,Ltd. (贵州百灵企业集团制药股份有限公司) (002424.SZ) reported a net profit of 136 million yuan in 2022, up 24.1% year-on-year.

Meanwhile, the company posted 3.5 billion yuan in revenue, up 13.8% year-on-year.

At the end of the reporting period, it had 6.9 billion yuan in total assets and 2.9 billion yuan in total liabilities, with a liability-to-asset ratio of 42%.